Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Vomiting × Injections, Intravenous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Ovarian Neoplasms 1 Neoplasms 1 Nausea 1 Head and Neck Neoplasms 1 Advanced Solid Tumor 1

Interventions

Dexamethasone 10 Palonosetron 8 casopitant 6 Ondansetron 6 Granisetron 6 Aprepitant 5 netupitant, palosentron drug combination 3 Duration of Therapy 2 netupitant 1 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 alizapride 1 Tropisetron 1 Tablets 1 NDC80 protein, human 1 Metoclopramide 1 Injections, Intravenous 1 Exercise 1 Docetaxel 1 Cyclophosphamide 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡